Overcoming Challenges in Infectious Diseases
Discover the latest medical research on the prevention, management and treatment of infectious diseases.
LATEST TOPICS
-
Klebsiella pneumoniae liver abscess: The impact of fluoroquinolones treatment on hospital length of stay4 August, 2021Professor Yi-Tsung Lin Professor of Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University; Attending Physician, Division of Infectious... -
Tofacitinib lowered mortality risk in patients hospitalised with COVID-19 pneumonia14 July, 2021Disease progression in COVID-19 is associated with an impaired immune response, which leads to a cytokine release syndrome, or hyperinflammatory state.1 Treatment or management of this response... -
Approaching Community-acquired Pneumonia (CAP) in the Age of COVID-198 July, 2021 -
Community-acquired pneumonia: Insights into macrolide resistance and a review of levofloxacin use5 July, 2021Dr Ton That Viet Hung Vice Director, Chief of Department of Examination Tam Tri Da Nang Hospital Vietnam According to the Survey of Antibiotic Resistance (SOAR) – an ongoing surveillance...
CONTENT LIBRARY
CONTENT LIBRARY
INTERVIEWS
-
Klebsiella pneumoniae liver abscess: The impact of fluoroquinolones treatment on hospital length of stay -
Community-acquired pneumonia: Insights into macrolide resistance and a review of levofloxacin use -
CAP in elderly: Diagnosis challenges and optimisation of antimicrobial therapy -
The antimicrobial properties therapeutic prospects of new generation quinolones -
Management of macrolide resistance in respiratory tract infections: An overview -
Sitafloxacin for bacterial infections: A Thailand perspective -
Vietnam: Management of macrolide resistance in cases of community-acquired pneumonia -
Management of urinary tract infection: Antibiotic selection -
Management of bronchiectasis: An overview -
Quinolones: Historical development and use